Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
| Image |  |
|---|---|
| Description | scientific article published on November 18, 2010 |
| Author/s |
author: Owen A. O'Connor Ann S LaCasce Wyndham H. Wilson Kieron Dunleavy |
| Publication date | November 18, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |